MicroRNA-708 targeting ZNF549 regulates colon adenocarcinoma development through PI3K/AKt pathway

Zhidong Zhao1, Xianju Qin2

  • 1Shanghai Eighth People's Hospital, Shanghai, 200235, China.

Scientific Reports
|October 8, 2020
PubMed

Insights

ZNF549 acts as a tumor suppressor in colon adenocarcinoma (COAD) by inhibiting cell proliferation and migration. It is targeted by miR-708-5p, which promotes COAD development via the PI3K/Akt pathway.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Colon adenocarcinoma (COAD) is a leading cause of cancer mortality.
  • Cys2-His2 zinc finger proteins (ZFPs) regulate crucial cellular processes including proliferation and apoptosis.
  • Identifying novel therapeutic targets for COAD is critical.

Purpose of the Study:

  • To identify and characterize novel tumor-inhibiting factors in COAD.
  • To investigate the role of ZNF549 and its regulation by miR-708-5p in COAD.
  • To elucidate the molecular mechanisms underlying ZNF549 and miR-708-5p in COAD progression.

Main Methods:

  • Bioinformatics analysis to identify potential targets.
  • Gene expression analysis (qRT-PCR, Western blot) in COAD tissues and cell lines.
  • Functional assays (proliferation, migration) upon ZNF549 or miR-708-5p manipulation.
  • Luciferase reporter assays to confirm gene targeting.
  • Analysis of the PI3K/Akt signaling pathway.

Main Results:

  • ZNF549 expression is significantly downregulated in COAD tissues and cell lines.
  • Overexpression of ZNF549 inhibits COAD cell proliferation and migration, while its knockdown promotes these processes.
  • miR-708-5p directly targets ZNF549, inhibiting its expression.
  • miR-708-5p promotes COAD cell proliferation and migration by activating the PI3K/Akt pathway and inducing Epithelial-mesenchymal transition (EMT).

Conclusions:

  • ZNF549 functions as a tumor suppressor in COAD.
  • The miR-708-5p/ZNF549 axis plays a critical role in COAD progression.
  • Targeting the miR-708-5p/ZNF549/PI3K/Akt pathway may offer a therapeutic strategy for COAD.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.9K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K